• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Almac expands, to create 229 jobs

Almac expands, to create 229 jobs

June 12, 2013
CenterWatch Staff

Craigavon-based Almac has announced a commercial manufacturing expansion. With the recent completion of a non-GMP drug development facility at the Craigavon site, this expansion represents a total investment of $10.3 million, including financial support from Invest Northern Ireland.  Up to 229 jobs will be created across both projects over the next three years.

The product, a laxative drug, which is contract manufactured by Almac, has recorded sales growth year-on-year throughout the U.K. and Europe. Almac is focusing all production in Northern Ireland, with additional equipment and resources in Craigavon. The investment will deliver blending equipment, an automated packing and integrated cartoning line, which will enable high-volume bulk commercial manufacturing beginning in November 2013.

Its new, 13,400-square-foot formulation development facility and analytical laboratories focuses on tablet and capsule formulations for new early-stage drugs.

 “The marketing and promotion of the product by our contract customer has been very effective and significant growth potential in several new territories, such as China, has been identified,” said Graeme McBurney, president and managing director of the business unit. “Centralizing and expanding our production in Craigavon will mean more cost-effective manufacturing and optimal quality control and distribution.”

 “This investment is good news for Craigavon and will reinforce Northern Ireland’s position in the wider life sciences sector,” said Arlene Foster, enterprise minister. “The 229 new jobs will deliver almost $4 million annually in salaries, bringing an important and positive economic boost which will benefit local people.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing